Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  155,071 results for ""Diabetes Mellitus, Type 2""

Your Filters

Subject : biomarkers Subject : diabetes mellitus, type 2 Subject : glucose intolerance Subject : metabolic syndrome Subject : renal insufficiency, chronic Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Risk of end-stage renal disease from chronic kidney disease defined by decreased glomerular filtration rate in type 1 diabetes: A comparison with type 2 diabetes and the effect of metabolic syndrome.

  • Authors : Lee YB; Division of Endocrinology and Metabolism, Department of Medicine, Korea University Guro Hospital, Seoul, Republic of Korea.; Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.

Subjects: Biomarkers/Biomarkers/Biomarkers/*analysis ; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*physiopathology ; Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/Diabetes Mellitus, Type 2/*physiopathology

  • Source: Diabetes/metabolism research and reviews [Diabetes Metab Res Rev] 2019 Nov; Vol. 35 (8), pp. e3197. Date of Electronic Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 100883450 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

The role of small dense LDL-C/large buoyant LDL-C ratio as an independent risk factor in patients with type 2 diabetes mellitus and metabolic syndrome

  • Authors : Wang C; Department of Endocrinology and Metabolism, Nanjing jiangbei Hospital Affiliated to Nantong University, Nanjing, 210048, China.; Li Y

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Annales de biologie clinique [Ann Biol Clin (Paris)] 2024 Jun 05; Vol. 82 (2), pp. 174-186.Publisher: John Libbey Eurotext Country of Publication: France NLM ID: 2984690R Publication Model: Print Cited Medium: Internet ISSN: 1950-6112

Record details

Read More Add to Saved list
×
Academic Journal

Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus.

  • Authors : Lucio-Gutiérrez JR; Universidad Autónoma de Nuevo León, Facultad de Medicina, Departamento de Química Analítica, Monterrey, Nuevo León, Mexico.; Cordero-Pérez P

Subjects: Metabolomics*/Metabolomics*/Metabolomics*/methods ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/blood ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/metabolism

  • Source: Journal of pharmaceutical and biomedical analysis [J Pharm Biomed Anal] 2024 Sep 01; Vol. 247, pp. 116240. Date of Electronic Publication: 2024 May 26.Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Cardio-renal-metabolic syndrome: clinical features and dapagliflozin eligibility in a real-world heart failure cohort.

  • Authors : Beles M; Cardiovascular Research Centre, OLV Hospital, Moorselbaan 164, 9300, Aalst, Belgium.; Masuy I

Subjects: Heart Failure*/Heart Failure*/Heart Failure*/drug therapy ; Heart Failure*/Heart Failure*/Heart Failure*/epidemiology ; Heart Failure*/Heart Failure*/Heart Failure*/diagnosis

  • Source: ESC heart failure [ESC Heart Fail] 2023 Aug; Vol. 10 (4), pp. 2269-2280. Date of Electronic Publication: 2023 Apr 24.Publisher: John Wiley & Sons Ltd on behalf of the European Society of Cardiology Country of Publication: England NLM ID: 101669191 Publication Model:

Record details

Read More Add to Saved list
×
Academic Journal

The Bidirectional Association of Chronic Kidney Disease, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, and Heart Failure: The Cardio-Renal-Metabolic Syndrome.

  • Authors : Nichols GA; Kaiser Permanente Center for Health Research, Portland, Oregon, USA.; Amitay EL

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Cardio-Renal Syndrome*/Cardio-Renal Syndrome*/Cardio-Renal Syndrome*/diagnosis

  • Source: Metabolic syndrome and related disorders [Metab Syndr Relat Disord] 2023 Jun; Vol. 21 (5), pp. 261-266. Date of Electronic Publication: 2023 May 02.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101150318 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
Academic Journal

New paradigm for the management of cardio-nephro-metabolic syndrome: multidisciplinary approach and role of telemedicine.

  • Authors : Giallauria F; Unit of Internal Medicine and Cardiac Rehabilitation, Department of Translational Medical Sciences, University of Naples Federico II, Naples, Italy.; Baratta R

Subjects: Diabetes Mellitus, Type 2* ; Metabolic Syndrome* ; Telemedicine*

  • Source: Minerva medica [Minerva Med] 2023 Jun; Vol. 114 (3), pp. 345-356. Date of Electronic Publication: 2022 Oct 18.Publisher: Edizioni Minerva Medica Country of Publication: Italy NLM ID: 0400732 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Evolution of sodium-glucose co-transporter 2 inhibitors from a glucose-lowering drug to a pivotal therapeutic agent for cardio-renal-metabolic syndrome.

Subjects: Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/therapeutic use ; Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/Sodium-Glucose Transporter 2 Inhibitors*/pharmacology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications

  • Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2023 Jan 30; Vol. 14, pp. 1111984. Date of Electronic Publication: 2023 Jan 30 (Print Publication: 2023).Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print

Record details

Read More Add to Saved list
×
Academic Journal

Health consequences of obesity and projected future obesity health burden in China.

  • Authors : Sun X; Global Health Institute, School of Public Health, Xi'an Jiaotong University, Xi'an, China.; Yan AF

Subjects: Cardiovascular Diseases*/Cardiovascular Diseases*/Cardiovascular Diseases*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/complications ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Obesity (Silver Spring, Md.) [Obesity (Silver Spring)] 2022 Sep; Vol. 30 (9), pp. 1724-1751.Publisher: John Wiley & Sons Country of Publication: United States NLM ID: 101264860 Publication Model: Print Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Latent autoimmune diabetes in youth shows greater autoimmunity than latent autoimmune diabetes in adults: Evidence from a nationwide, multicenter, cross-sectional study.

  • Authors : Cheng J; Department of Metabolism and Endocrinology, The Second Xiangya Hospital, Central South University, Changsha, China.; Key Laboratory of Diabetes Immunology (Central South University), Ministry of Education, National Clinical Research Center for Metabolic Diseases, Changsha, China.

Subjects: Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/Diabetes Mellitus, Type 1*/epidemiology ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/diagnosis ; Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology

  • Source: Pediatric diabetes [Pediatr Diabetes] 2022 Aug; Vol. 23 (5), pp. 578-587. Date of Electronic Publication: 2022 May 17.Publisher: Munksgaard Country of Publication: Denmark NLM ID: 100939345 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read More Add to Saved list
×
Academic Journal

Long-term influence of type 2 diabetes and metabolic syndrome on all-cause and cardiovascular death, and microvascular and macrovascular complications in Chinese adults - A 30-year follow-up of the Da Qing diabetes study.

  • Authors : He S; Endocrinology Centre, Fuwai Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing China.; Wang J

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Glucose Intolerance*/Glucose Intolerance*/Glucose Intolerance*/complications ; Glucose Intolerance*/Glucose Intolerance*/Glucose Intolerance*/epidemiology

  • Source: Diabetes research and clinical practice [Diabetes Res Clin Pract] 2022 Sep; Vol. 191, pp. 110048. Date of Electronic Publisher: Elsevier Scientific Publishers Country of Publication: Ireland NLM ID: 8508335 Publication Model: Print-Electronic Cited Medium: Internet

Record details

Read More Add to Saved list
×
  • 1-10 of  155,071 results for ""Diabetes Mellitus, Type 2""